Related Experiment Video
Updated: Apr 19, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
The effects of passive smoking on the six-minute walk test in obese pediatric cases
Nazan Kaymaz1, Şule Yıldırım, Mustafa Tekin
1Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Pediatrics, Çanakkale, Turkey. E-ma-il: sule.yildirim@comu.edu.tr.
Insights
Second-hand smoke exposure significantly reduced the six-minute walk test (6 MWT) distance in obese children. This finding highlights potential respiratory and cardiovascular risks in this vulnerable pediatric population.
Area of Science:
- Pediatric Pulmonology
- Environmental Health
- Cardiopulmonary Function
Background:
- Obese children face increased risk of reduced cardiopulmonary function.
- Exposure to environmental tobacco smoke is a significant health concern for children.
Purpose of the Study:
- To investigate the impact of second-hand smoke exposure on the six-minute walk test (6 MWT) in obese, non-asthmatic children.
- To assess the association between passive smoking and exercise capacity in pediatric obesity.
Main Methods:
- Seventy-five obese pediatric patients (BMI >95th percentile) without comorbidities were enrolled.
- Participants were categorized into groups based on parental-reported passive smoking exposure.
- The six-minute walk test (6 MWT) and spirometry were performed on all subjects.
Main Results:
- Children exposed to passive smoking (Group 1) walked a mean of 501.88 ± 62.12 meters.
- Children not exposed to passive smoking (Group 2) walked a mean of 559.63 ± 72.93 meters.
- A statistically significant difference (p=0.001) was observed in 6 MWT distance between the groups.
Conclusions:
- Passive smoking negatively impacts respiratory and cardiovascular capacity in obese children.
- The 6 MWT is a valuable tool for monitoring cardiopulmonary function in these pediatric patients.
- Educating families about the risks of passive smoking is crucial for protecting children's health.
Objective:
The aim of this study was to evaluate whether exposure to second-hand smoke affected the six-minute walk test (6 MWT) of obese non-asthmatic pediatric cases.
Methods:
Obese pediatric patients (body mass index >95th p) with no existing co-morbidities were included in the study. Smoke exposure was assessed with a self-reported questionnaire completed by the parents. The subjects were divided into two groups: Group 1 consisting of obese children exposed to passive smoking and Group 2 of obese children not exposed to passive smoking. In addition to 6 MWT, spirometric flow and volume, including forced expiratory volume in 1 s and peak expiratory flow rate, were also measured in all subjects. The results of the 6 MWT were assessed to determine any association with passive smoking.
Results:
The study included 75 obese pediatric cases (40 male, 35 female) with a mean age of 9.06 ± 0.97 years. The 6 MWT results in Group 1 was 501.88 ± 62.12 meters and in Group 2 559.63 ± 72.93 meters. The difference was statistically significant (p=0.001).
Conclusions:
Passive smoking may negatively affect the respiratory and cardiovascular capacity in obese children, who are already at risk of lower cardiopulmonary function. The evaluation of 6 MWT in these pediatric patients may be useful for monitoring and families should be warned about potential problems due to smoking.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...